{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T05:41:03Z","timestamp":1770270063026,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s11427-015-4930-4","type":"journal-article","created":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T18:44:00Z","timestamp":1443638640000},"page":"1276-1281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Characteristics of the TCR V\u03b2 repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations"],"prefix":"10.1007","volume":"58","author":[{"given":"Ling","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YuHong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YiKai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZhenYi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XianFeng","family":"Zha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ShaoHua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LiJian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YangQiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,1]]},"reference":[{"key":"4930_CR1","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0140-6736(13)62120-0","volume":"385","author":"JF Apperley","year":"2015","unstructured":"Apperley JF. Chronic myeloid leukaemia. The Lancet, 2015, 385: 1447\u20131459","journal-title":"The Lancet"},{"key":"4930_CR2","first-page":"69","volume":"115","author":"Y Li","year":"2002","unstructured":"Li Y, Yang L, Chen S, Li R, Zhang Y, Lu Y, Luo G. Clonal expansion T cells identified in acute monoblastic leukemia by CDR3 size analysis of TCR T beta repertoire using RT-PCR and genescan. Chin Med J (Engl), 2002, 115: 69\u201371","journal-title":"Chin Med J (Engl)"},{"key":"4930_CR3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMoa011573","volume":"346","author":"H Kantarjian","year":"2002","unstructured":"Kantarjian H, Sawyers C, Hochhaus A, Guilhot F, Schiffer C, Gambacorti-Passerini C, Niederwieser D, Resta D, Capdeville R, Zoellner U, Talpaz M, Druker B, Goldman J, O\u2019Brien SG, Russell N, Fischer T, Ottmann O, Cony-Makhoul P, Facon T, Stone R, Miller C, Tallman M, Brown R, Schuster M, Loughran T, Gratwohl A, Mandelli F, Saglio G, Lazzarino M, Russo D, Baccarani M, Morra E. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med, 2002, 346: 645\u2013652","journal-title":"N Engl J Med"},{"key":"4930_CR4","first-page":"136","volume":"52","author":"N Usui","year":"2004","unstructured":"Usui N. Molecular targeted treatment\u2014new treatment strategy for patients with chronic myeloid leukemia. Rinsho Byori, 2004, 52: 136\u2013144","journal-title":"Rinsho Byori"},{"key":"4930_CR5","volume-title":"Sci China Life Sci","author":"KH Kok","year":"2012","unstructured":"Kok KH, Tang HM, Jin DY. \u2018One Health\u2019 for the people of Hong Kong and the world. Sci China Life Sci, 2012, doi: 10.1007\/s11427-012-4408-6"},{"key":"4930_CR6","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1038\/sj.leu.2404318","volume":"20","author":"E Jabbour","year":"2006","unstructured":"Jabbour E, Kantarjian H, Jones D, Talpaz M, Bekele N, O\u2019Brien S, Zhou X, Luthra R, Garcia-Manero G, Giles F, Rios MB, Terstovsek S, Cortes J. Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate. Leukemia, 2006, 20: 1767\u20131773","journal-title":"Leukemia"},{"key":"4930_CR7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1535-6108(02)00096-X","volume":"2","author":"NP Shah","year":"2002","unstructured":"Shah NP, Nicoll JM, Nagar B, Gorre ME, Paquette RL, Kuriyan J, Sawyers CL. Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia. Cancer Cell, 2002, 2: 117\u2013125","journal-title":"Cancer Cell"},{"key":"4930_CR8","first-page":"188","volume-title":"Hematology Am Soc Hematol Educ Program","author":"R Ilaria","year":"2005","unstructured":"Ilaria RL Jr. Pathobiology of lymphoid and myeloid blast crisis and management issues. Hematology Am Soc Hematol Educ Program, 2005, 188\u2013194"},{"issue":"2","key":"4930_CR9","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1007\/s00277-015-2324-0","volume":"94","author":"S Saussele","year":"2015","unstructured":"Saussele S, Silver RT. Management of chronic myeloid leukemia in blast crisis. Ann Hematol, 2015, 94 Suppl 2: S159\u2013S165","journal-title":"Ann Hematol"},{"issue":"2","key":"4930_CR10","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1007\/s00277-015-2325-z","volume":"94","author":"B Chereda","year":"2015","unstructured":"Chereda B, Melo JT. Natural course and biology of CML. Ann Hematol, 2015, 94 Suppl 2: S107\u2013S121","journal-title":"Ann Hematol"},{"key":"4930_CR11","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S1470-2045(07)70342-X","volume":"8","author":"JF Apperley","year":"2007","unstructured":"Apperley JF. Part I: Mechanisms of resistance to imatinib in chronic myeloid leukaemia. Lancet Oncol, 2007, 8: 1018\u20131029","journal-title":"Lancet Oncol"},{"key":"4930_CR12","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1126\/science.286.5441.958","volume":"286","author":"TP Arstila","year":"1999","unstructured":"Arstila TP, Casrouge A, Baron T, Even J, Kanellopoulos J, Kourilsky P. A direct estimate of the human alphabeta T cell receptor diversity. Science, 1999, 286: 958\u2013961","journal-title":"Science"},{"key":"4930_CR13","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1073\/pnas.1409155111","volume":"111","author":"Q Qi","year":"2014","unstructured":"Qi Q, Liu Y, Cheng Y, Glanville J, Zhang D, Lee JY, Olshen RA, Weyand CM, Boyd SD, Goronzy JJ. Diversity and clonal selection in the human T-cell repertoire. Proc Natl Acad Sci USA, 2014, 111: 13139\u201313144","journal-title":"Proc Natl Acad Sci USA"},{"key":"4930_CR14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nri1292","volume":"4","author":"J Nikolich-Zugich","year":"2004","unstructured":"Nikolich-Zugich J, Slifka MK, Messaoudi I. The many important facets of T-cell repertoire diversity. Nat Rev Immunol, 2004, 4: 123\u2013132","journal-title":"Nat Rev Immunol"},{"key":"4930_CR15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.trim.2007.05.011","volume":"18","author":"Y Li","year":"2007","unstructured":"Li Y, Chen S, Yang L, Yin Q, Geng S, Wu X, Schmidt CA, Przybylski GK. TRAT and TRBT repertoire, clonality and the proliferative history of umbilical cord blood T-cells. Transpl Immunol, 2007, 18: 151\u2013158","journal-title":"Transpl Immunol"},{"key":"4930_CR16","first-page":"840","volume":"117","author":"Y Li","year":"2004","unstructured":"Li Y, Yang L, Chen S, Zhang Y, Zhang X, Luo G. T cell receptor Tbeta repertoire usage and clonal expansion of T cells in chronic myelogenous leukemia. Chin Med J (Engl), 2004, 117: 840\u2013843","journal-title":"Chin Med J (Engl)"},{"key":"4930_CR17","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.humimm.2011.06.015","volume":"72","author":"X Zha","year":"2011","unstructured":"Zha X, Chen S, Yang L, Li B, Chen Y, Yan X, Li Y. Characterization of the CDR3 structure of the Tbeta21 T cell clone in patients with P210(BCR-ABL)-positive chronic myeloid leukemia and B-cell acute lymphoblastic leukemia. Hum Immunol, 2011, 72: 798\u2013804","journal-title":"Hum Immunol"},{"key":"4930_CR18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1089\/dna.2013.2277","volume":"33","author":"Z Jin","year":"2014","unstructured":"Jin Z, Wu X, Chen S, Yang L, Liu Q, Li Y. Distribution and clonality of the v\u03b1 and v\u03b2 T-cell receptor repertoire of regulatory T cells in leukemia patients with and without graft versus host disease. DNA Cell Biol, 2014, 33: 182\u2013188","journal-title":"DNA Cell Biol"},{"key":"4930_CR19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1179\/102453311X12902908411634","volume":"16","author":"Y Li","year":"2011","unstructured":"Li Y, Geng S, Du X, Chen S, Yang L, Wu X, Li B, Schmidt CA, Przybylski GK. Restricted TRBT repertoire in CD4+ and CD8+ T-cell subsets from CML patients. Hematology, 2011, 16: 43\u201349","journal-title":"Hematology"},{"key":"4930_CR20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/10245330310001621288","volume":"8","author":"Y Li","year":"2003","unstructured":"Li Y. Leukemia associated clonal expansion of TCR Tbeta subfamily T cells. Hematology, 2003, 8: 375\u2013384","journal-title":"Hematology"},{"key":"4930_CR21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/10245330500226662","volume":"10","author":"Y Li","year":"2005","unstructured":"Li Y, Yang L, Chen S, Zhang Y, Wu X. The TCR Tbeta repertoire usage of T-cells from cord blood induced by chronic myelogenous leukemia associated antigen. Hematology, 2005, 10: 387\u2013392","journal-title":"Hematology"},{"key":"4930_CR22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4049\/jimmunol.163.1.443","volume":"163","author":"P thor Straten","year":"1999","unstructured":"thor Straten P, Guldberg P, Gronbaek K, Hansen MR, Kirkin AF, Seremet T, Zeuthen J, Becker JC. In situ T cell responses against melanoma comprise high numbers of locally expanded T cell clonotypes. J Immunol, 1999, 163: 443\u2013447","journal-title":"J Immunol"},{"key":"4930_CR23","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1172\/JCI119601","volume":"100","author":"EJ Claret","year":"1997","unstructured":"Claret EJ, Alyea EP, Orsini E, Pickett CC, Collins H, Wang Y, Neuberg D, Soiffer RJ, Ritz J. Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion. J Clin Invest, 1997, 100: 855\u2013866","journal-title":"J Clin Invest"},{"key":"4930_CR24","first-page":"260","volume":"88","author":"S Marktel","year":"2003","unstructured":"Marktel S, Marin D, Foot N, Szydlo R, Bua M, Karadimitris A, De Melo TA, Kotzampaltiris P, Dazzi F, Rahemtulla A, Olavarria E, Apperley JF, Goldman JM. Chronic myeloid leukemia in chronic phase responding to imatinib: the occurrence of additional cytogenetic abnormalities predicts disease progression. Haematologica, 2003, 88: 260\u2013267","journal-title":"Haematologica"},{"key":"4930_CR25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1756-8722-3-14","volume":"3","author":"L Wang","year":"2010","unstructured":"Wang L, Zhu K, Zha X, Chen S, Yang L, Chen S, Li Y. Evolution of T-cell clonality in a patient with Ph-negative acute lymphocytic leukemia occurring after interferon and imatinib therapy for Ph-positive chronic myeloid leukemia. J Hematol Oncol, 2010, 3: 14","journal-title":"J Hematol Oncol"},{"key":"4930_CR26","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s11427-014-4702-6","volume":"57","author":"Q Wang","year":"2014","unstructured":"Wang Q, Cheng T. Evidences for mutations in the histone modifying gene SETD2 as critical drivers in leukemia development. Sci China Life Sci, 2014, 57: 944\u2013946","journal-title":"Sci China Life Sci"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-015-4930-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T19:51:59Z","timestamp":1692042719000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11427-015-4930-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,1]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["4930"],"URL":"https:\/\/doi.org\/10.1007\/s11427-015-4930-4","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,1]]}}}